We demonstrated that both drugs exhibited a greater growth-inhibitory effect in VCaP cells compared to other three cell lines (Fig. 6a, b), suggesting that TMPRSS2-ERG and p53 mutant-positive PCa cells are hyper-vulnerable to the inhibition of β-Catenin by these two compounds. This evidence concerns the gene TMPRSS2 and posterior cortical atrophy.